Senior insider sale
Chief Medical Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$813.4K
142.60K shares
What this filing means
JAMIL KHURRAM plans to sell 142.60K shares of GALECTIN THERAPEUTICS INC valued at approximately $813.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/17/2025ACC: 0001972481-25-000318
Officer· Chief Medical Officer
Since Aug 2024
142.60K
Shares to sell
$813.4K
Approx. market value
254.48K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Restricted Stock Units
Equity Compensation
12/20/2024
4.48KOption Exercise
Cash
8/1/2024
100KOption Exercise
Cash
3/20/2024
150KTotal acquired254.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/20/2024 | Restricted Stock Units Equity Compensation | 4.48K | — |
8/1/2024 | Option Exercise Cash | 100K | — |
3/20/2024 | Option Exercise Cash | 150K | — |
| Total | 254.48K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
121.12K
Market value
$662.2K
11/13/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
21.48K
Market value
$151.2K
12/17/2025
Total
Units
142.60K
Value
$813.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/13/2025 | 121.12K | $662.2K | — | Completed |
| Planned — Approximate Date | ||||
12/17/2025 | 21.48K | $151.2K | Nasdaq | Planned |
| Total | 142.60K | $813.4K | ||